Elsevier (Cell Press & The Lancet) is a company within the Academic Publishing category. Elsevier, a global leader in information and analytics, operates prestigious editorial brands including Cell Press and The Lancet. These brands publish high-impact scientific and medical research through specialized journals and interdisciplinary collaborations.
Elsevier (Cell Press & The Lancet) was founded in 1880 and is headquartered in Amsterdam, Netherlands.
Elsevier (Cell Press & The Lancet) is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Elsevier (Cell Press & The Lancet) is Strong. Minor factual deltas detected.
AI models classify Elsevier (Cell Press & The Lancet) as a Challenger. AI names competitors first.
Elsevier (Cell Press & The Lancet) appeared in 7 of 8 sampled buyer-intent queries (88%). The brand dominates high-intent queries but faces competition from open-access journals and 'Nature' in broader research discovery queries.
AI reliably identifies the prestige and corporate lineage of these brands. However, it may struggle to define the precise relationship between them when they are grouped as a single entity, often defaulting to a generic 'Elsevier-owned' description. Key gap: AI often treats 'Cell Press' and 'The Lancet' as a single entity when queried this way, failing to distinguish that they are separate editorial houses with different internal cultures and peer-review processes under a shared corporate parent.
Of 5 key facts verified about Elsevier (Cell Press & The Lancet), 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Confusing the specific business relationship/joint-venture status of products like 'EBioMedicine' or 'EClinicalMedicine' which are co-branded.
Buyers turn to Elsevier (Cell Press & The Lancet) for Manual Literature Review: Individual researchers or institutions manually searching through disparate open-access repositories and pre-print servers., General Web Search: Using general search engines or non-curated AI summaries without verifying primary source peer-reviewed data., among 2 documented problem areas.
Buyers evaluating Elsevier (Cell Press & The Lancet) typically ask AI models about "highest impact factor medical journals", "where to publish cell biology research", "latest covid-19 clinical trials lancet", and 3 similar queries.
Elsevier (Cell Press & The Lancet)'s main competitors are PLOS (Public Library of Science). According to AI models, these are the brands most frequently named alongside Elsevier (Cell Press & The Lancet) in buyer-intent queries.
Elsevier (Cell Press & The Lancet)'s core products are Academic journals, clinical decision support tools, research databases (Scopus, ScienceDirect)..
Elsevier (Cell Press & The Lancet) uses Subscription and Article Processing Charges (APC) for Open Access..
Elsevier (Cell Press & The Lancet) serves Medical professionals, academic researchers, healthcare institutions, and R&D departments..
Elsevier (Cell Press & The Lancet) Unrivaled historical prestige and the highest aggregate impact factors across clinical medicine and molecular biology.
Brand Authority Index (BAI) tier: Leader (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/elsevier-cell-pressthe-lancet
Last analyzed: April 11, 2026
Founded: 1880 (Elsevier), 1823 (The Lancet), 1974 (Cell Press)
Headquarters: Amsterdam, Netherlands (Elsevier)